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S
ignificant advances have been
achieved in the synthesis and modifi-
cation of the inorganic nanoparticles
(NPs) for biomedical applications. These
nanosized materials offer a robust frame-
work in which two or more functional build-
ing blocks can be incorporated to give mul-
tiple functionalities. For example,
molecularly mediated assembly of noble
metals such as Ag and Au NPs has been
used for designing sensors, bioprobes, im-
aging diagnosis, and photothermal cancer
therapy.15 To sustain life and maintain bio-
logical function, nature requires systems
that can offer multiple specific abilities in re-
sponse to their surrounding environments.
While noble metal NPs exhibit size-, shape-,
and interdistance-dependent optical, elec-
tronic, and photothermal conversion
properties,17 they generally lack sensitivity
to local environment change. Smart poly-
mers that can undergo conformational and
chemical changes in response to external
stimuli, such as temperature, pH, or glucose
level,811 are often prepared for a broad
range of application. Noble metal NPs
coated with smart polymers can adapt to
surrounding environments, convert chemi-
cal and biochemical signals (e.g., disruptions
in temperature and/or pH homeostasis
that are associated with pathological
zone)12,13 into optical signals,1416 capture
the analyte close to noble metal NPs for
surface-enhanced Raman scattering analy-
sis,17 and regulate the release of preloaded
drug.18 The capability of simultaneous opti-
cal diagnosis and therapy with NPs may
prove to be advantageous over conven-
tional medicine.
In this text, we describe the construc-
tion of multifunctional hybrid nanogels
that are designed for a combination of opti-
cal detection of glucose at physiological
pH and temperature with self-regulated in-
sulin release (Figure 1). There is an urgent
need to develop a nanobiosensor for con-
tinuous glucose monitoring at physiologi-
cal conditions in subjects with diabetes mel-
litus,19 which represents one of the largest
health concerns of the 21st century with
worldwide prevalence. The most investi-
gated methods for glucose measurement
utilize the enzyme glucose oxidase. Al-
though significant benefits have already
been achieved, enzyme-based systems suf-
fer from instabilities due to denaturation,
difficulties associated with sterilization, and
cost when used in a format suitable for con-
tinuous sensing.19 This has led to consider-
able research interest in developing syn-
thetic boronic acid ligands for binding and
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ABSTRACT Optical detection of glucose, high drug loading capacity, and self-regulated drug delivery are
simultaneously possible using a multifunctional hybrid nanogel particle under a rational design in a colloid
chemistry method. Such hybrid nanogels are made of Ag nanoparticle (NP) cores covered by a copolymer gel
shell of poly(4-vinylphenylboronic acid-co-2-(dimethylamino)ethyl acrylate) [p(VPBADMAEA)]. The introduction
of the glucose sensitive p(VPBADMAEA) gel shell onto Ag NPs makes the polymer-bound Ag NPs responsive to
glucose. While the small sized Ag cores (10  3 nm) provide fluorescence as an optical code, the responsive
polymer gel shell can adapt to a surrounding medium of different glucose concentrations over a clinically relevant
range (030 mM), convert the disruptions in homeostasis of glucose level into optical signals, and regulate
release of preloaded insulin. This shows a new proof-of-concept for diabetes treatment that exploits the properties
from each building block of a multifunctional nano-object. The highly versatile multifunctional hybrid nanogels
could potentially be used for simultaneous optical diagnosis, self-regulated therapy, and monitoring of the
response to treatment.
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detecting glucose.20 These boronic acid-based ligands
have been coupled with polymer for continuous glu-
cose sensing,911,2126 including the holographic sen-
sors based on the phenylboronic acid (PBA) copolymer
film21,25 and the photonic crystal glucose sensors based
on the PBA-modified hydrogels.22 While these glucose
sensors exploited a change in diffraction or reflection,
fluorescence-based systems are receiving increasing at-
tention, encouraged by their special advantages for bio-
logical analysis with little or no damage to the host sys-
tem. Different fluorescent organic moieties19,27,28 and
semiconductor quantum dots (QDs)2932 have been
coupled with the boronic acid-based ligands. Tech-
niques include measuring the changes in fluorescence
resonance energy transfer (FRET) between a fluorescent
donor and an acceptor because of competitive
displacement,2931 and glucose-induced changes in in-
trinsic fluorescence of enzymes or extrinsic optical la-
bels.32 The advantages for QDs over organic fluoro-
phores, including multicolor imaging, photostability,
and high quantum yield, are significant, but the poten-
tial hazards caused by the release of cadmium are of se-
rious concern.33 An alternative to fluorophores or QDs
for the labeling of glucose responsive polymers is the
use of biocompatible noble metal NPs, because small
sized noble metal NPs can offer strong and nonbleach-
ing fluorescence.34,35 Geddes’s group reported a glu-
cose sensor based on the Ag NPs capped with small
molecules of thiolated boronic acid.34 The interaction
of glucose and dextran with thiolated boronic acid-
capped silver nanoparticles in solution resulted in en-
hanced fluorescence intensity. On the other hand, the
hydrogel beads, micro/nanogels, or mesoporous silica,
offering the unique advantage of interior network struc-
ture for the incorporation of therapeutics, are being ac-
tively explored as carriers for insulin delivery.10,3640 To
adjust treatment to maintain near-normoglycaemia, in
some cases glucose-sensitive polymers are employed,
and the release of insulin can be regulated by glucose-
responsive swelling/shrinking of the polymer
networks.10,39 While a variety of monofunctional materi-
als for either glucose detection or insulin delivery have
been developed, unfortunately, to the best of our
knowledge, no report of the multifunctional nanocar-
rier systems combining both optical glucose detection
and insulin delivery has appeared in the literature. The
combination of optical glucose with self-regulated insu-
lin delivery into a single nano-object can potentially
provide simultaneous diagnosis, therapy, and monitor-
ing of the response to treatment.
Herein, we design a novel class of coreshell colloi-
dal nanobiomaterials comprising small Ag NPs (10  3
nm) coated with new boronate derivative, poly(4-
vinylphenylboronic acid-co-2-(dimethylamino)ethyl
acrylate) [p(VPBADMAEA)] nanogel network chains,
as glucose recognition element. The p(VPBADMAEA)
gel shell can undergo a volume phase transition in re-
sponse to the change in glucose concentration with
high sensitivity and selectivity over a clinically relevant
range (030 mM) at the physiological pH and temper-
ature upon a rational design of the polymer chains.
While the small-sized Ag NP core can provide these hy-
brid nanogels with strong fluorescence, the glucose-
induced swelling/shrinking of the p(VPBADMAEA) gel
shell is expected to modify the physicochemical envi-
ronment of the Ag NP core for manipulation of the fluo-
rescence intensity, converting the variation in glucose
level to optical signals. In addition to the signaling abil-
ity for glucose level change, we also demonstrated
that these hybrid nanogel systems can modulate the
delivery of preloaded insulin as a function of glucose
level. The ability to track drug-loaded NPs in biological
systems, optically detect glucose level, and intelligently
dose the insulin of the multifunctional hybrid nanogels
may hasten the development of more efficacious sys-
tems toward a good diabetic control.
RESULTS AND DISCUSSION
Following the main objective to probe glucose level
and deliver insulin under physiological pH and temper-
ature conditions, our strategy to prepare these novel
multifunctional hybrid nanogels is based on a combina-
tion of several methods previously developed in both
inorganic NP and polymer synthesis. First, the synthe-
sis of noble metal NPs with controlled size, shape, and
thus unique optical properties has been well estab-
lished by several groups.6,7 Second, while various bo-
ronic acid-based glucose recognition elements have
been intensively developed,1922 our group and other
groups have previously employed poly(N-
isopropylacrylamide-co-phenylboronic acid), poly(N-
isopropylacrylamide-co-acrylamide-co-phenylboronic
acid) and other poly(N-isopropylacrylamide) based
polymers to fabricate polymeric micro/nanogel with
glucose-induced volume phase transition profiles.911
Third, we have recently reported the buildup of temper-
ature and pH sensitive poly(N-isopropylacrylamide-co-
acrylic acid) shell on CTAB-capped Ag NPs (36  3 nm)
following the method developed by Liz-Marzán’s
group,16,17 as well as the subsequent upload and pH-
controlled release of drugs for cancer therapy.15 These
different procedures can be combined in such a way
Figure 1. Schematic illustration of smart hybrid nanogels
that can integrate optical glucose detection and self-
regulated insulin delivery at physiological pH and tempera-
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that involves the first synthesis of SDS-capped Ag NPs
(10  3 nm), followed by the free-radical precipitation
polymerization of the monomers to form a glucose re-
sponsive gel shell of a new copolymer
p(VPBADMAEA) on the Ag NPs templates, so that the
glucose-sensitive and fluorescent components can be
integrated into a single nano-object. To avoid or mini-
mize the formation of free nanogel spheres and to
make sure that the Ag NP was encapsulated inside the
hybrid nanogel, the concentrations of Ag NPs, SDS, and
monomers were optimized for the one-step encapsula-
tion of metal NPs within the p(VPBADMAEA) nano-
gel. With the similar Q values and the large difference
in e values of VPBA (Q  0.38, e  0.52)41 and DMAEA
(Q  0.54, e  0.61)42 monomers, the resulting
p(VPBADMAEA) gel shell may possess alternating
functional VPBA and DMAEA units through the net-
work chains.
After the coating of the gel layer, the absorption
peak of the Ag NPs red-shifted by 26 nm (Figure 2E).
This red-shift is related to a change in the local dielec-
tric constant around the Ag NPs resulted from the coat-
ing of the p(VPBADMAEA) gel layer onto the Ag
NPs.17,43,44 As shown in Figure 2, the resultant
coreshell particles have a spherical morphology with
a very narrow size distribution (Supporting Information,
Figure S1). The markedly high electron density of Ag en-
ables direct visualization of the Ag NP core within the
p(VPBADMAEA) nanogels. The hybrid nanogel syn-
thesized with only VPBA but no DMAEA (as a control),
coded as AVD-4, has the smallest size of only about 136
nm. After being copolymerized with DMAEA, the gel
layer becomes thicker, and the thickness increases with
the increase in DMAEA feeding. The hybrid nanogels
AVD-3 (4.64 wt % DMAEA), AVD-2 (8.86 wt %) and
AVD-1 (16.28 wt %) have an increased size of 139, 165,
and 172 nm, respectively. The controllable size of the
hybrid nanogels is very important to their fate in the
bloodstream. Recognition by the reticuloendothelial
system (RES) is known to be the principal reason for the
removal of many colloidal drug carriers from the blood
compartment.45 The sub-200 nm size is desirable for
colloidal particles to extend their blood circulation time.
The working pH is directed by the choice of func-
tional groups in a glucose-sensing system, since the
pKa of the glucose receptor, here the phenylboronic
acid (PBA) group, is an essential parameter for its selec-
tive binding and detection of glucose. Figure 3A shows
the pH-induced volume phase transitions of the hybrid
nanogels in terms of the change of hydrodynamic ra-
dius (Rh) measured at 37.2 °C. The pH-dependent phase
behavior has been observed due to the presence of
DMAEA (pKb  7.5) and VPBA (pKa  8.9) moieties. The
amino groups in the pDMAEA segments were slightly
ionized at the physiological pH and still not completely
ionized at pH  4.5. The swelling onset corresponding
to the VPBA moiety in AVD-4 remained at about pH 8.8,
whereas a decrease in the onset pH to about 7.88.0
Figure 2. TEM images of the hybrid nanogels dried from the medium of pH  7.4: (A) AVD-1, (B) AVD-2, (C) AVD-3, and (D)
AVD-4. (E) Typical UVvis absorption and excitation spectra of the hybrid nanogels. As a comparison, the absorption spec-
trum of the free Ag NPs is also presented.
Figure 3. (A) pH-dependent average Rh values of the hybrid nanogels. (B)
Glucose-dependent average Rh values, in PBS of pH  7.38. All measure-
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was found in all other hybrid nanogels containing the
DMAEA moiety. The PBA group is in equilibrium be-
tween the undissociated (trigonal, uncharged) and the
dissociated (tetrahedral, charged) forms in aqueous so-
lution.20 Both forms react reversibly with 1,2-cis-diols
such as glucose. The complexation of the uncharged
form with glucose is unstable because it is highly sus-
ceptible to hydrolysis, but the binding of glucose in-
duces the thermodynamically more favorable charged
form. Two methods were previously proposed to en-
hance glucose recognition at physiological pH by
either designing boronate analogues with lower pKa
values21,22 or introducing intramolecular B · · · X
bonds that confer a tetrahedral conformation at the bo-
ron center through the neighboring effect of an ortho
group.23,26,38 While sometimes the preparation proto-
cols for the former are rigorous and time-consuming,
the latter approach is more appealing. The presence of
glucose can move the dissociation equilibrium of PBA
to the right and further decrease its pKa,20 so if a strong
intramolecular B · · · X bond can be generated, then
such boronic acids would bind glucose at physiologi-
cal pH. The effect of introducing a fixed positive charge
in PBA hydrogel film was reported earlier by Horgan25
and Lowe,21 respectively, by using a quaternary amine
of (3-acrylamidopropyl)trimethylammonium chloride
(ATMA). In our design, a Lewis base DMAEA with small
ionization, rather than a cation like ATMA, is demon-
strated to be also useful to enhance the binding affin-
ity of PBA to glucose at physiological pH range. The bo-
ronate ester in the hybrid nanogels is stabilized by
electrostatic attraction (BN) through the adjacent
slightly protonated dimethyl amino groups, which
should be stronger than the intramolecular interac-
tions between boronate with neutral amide groups re-
ported previously.16,23,46,47
Figure 3B shows that the swelling process of hybrid
nanogels upon the addition of glucose can elegantly
occur at pH  7.4. The complexation of glucose with
the hybrid nanogels increases the fraction of negatively
charged boronates. At very low glucose concentra-
tions (e.g.,  0.75 mM), the complexation-induced
negative charges on the boronates are electrostatically
attracted to the slightly protonated DMAEA moieties in
the hybrid nanogels, resulting in an initial decrease in
Rh due to the charge neutrality (Supporting Information,
Figure S2). On further increasing the glucose concentra-
tion, the overall charge of the hybrid nanogels changes
from slightly positive to negative. The binding of glu-
cose to the PBA increases the charge density on the gel
and builds up a Donnan potential for the gel to swell
steadily with an increase in glucose concentration. The
swelling ratio, Rh,30 mM/Rh,0 mM, of AVD-1, AVD-2, and
AVD-3 were found to be 1.71, 1.70, and 1.70, respec-
tively, demonstrating the high sensitivity of these hy-
brid nanogels to glucose. In contrast, AVD-4 gave a
much mild change in the overall response to glucose
and a smaller Rh,30 mM/Rh,0 mM  1.46, because the com-
plexation of the uncharged PBA with glucose is un-
stable and it is highly susceptible to hydrolysis when
the pH ( 7.4) is far below the pKa (8.9).
The glucose-responsive gel shell can modify the
physicochemical environment of the Ag core NPs, con-
verting biochemical signals into optical signals (Figure 4
and Supporting Information, Figure S3). As the size of
Ag NPs is far smaller than the electron mean free path
length (50 nm),46,47 robust photoluminescence (PL)
can be detected from the hybrid nanogels dispersed in
PBS at pH  7.38. A slightly broadened absorption but
a minimum of the excitation spectrum at the absorp-
tion peak of the hybrid nanogels (Figure 2E) can further
confirm that plasmons do not make major contribu-
tions to the luminescence; rather, the luminescence
likely arises from single-electron excitations between
discrete energy states.48,49 The PL of Ag core NPs is
gradually quenched when the gel shell gradually swells
up at the elevated glucose concentrations (Figure 4A,B).
The comparison of Figure 4B with Figure 3B indicates
that a conspicuous fluorescent response levels off at
nearly the same glucose level where the gel network
chains stretch to nearly a maximum. The linear plot
(Supporting Information, Figure S4) gives the relation-
ship in a more orthogonal fashion. The detection sensi-
bility is estimated to be 0.1 mM. The effect of the
DMAEA moiety on the swelling ratio is also reflected in
the fluorescent response, which shows that the incor-
poration of DMAEA has led to a much higher optical
glucose sensitivity. It should be mentioned that glu-
cose in the tested concentration range of 030 mM has
Figure 4. (A) Photoluminescence (PL) response of AVD-1 to glucose,
showing typical evolution of the PL spectra. (B) Quenched PL at 618
nm as a function of the concentration of glucose. (C) Glucose response
in the presence of 0.8 mM L-lactate. (D) PL quenching and recovery
cycles upon the repeated addition (30.0 mM) and dialysis removal of
glucose (0 mM) in the dispersion medium of the corresponding hybrid
nanogels. All measurements were made in PBS of pH  7.38 and 37 °C.
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no effect on the fluorescence of free Ag NPs. One rea-
son for this PL property change of Ag NP cores in the
hybrid nanogels is associated with the variation of the
Rayleigh scattering through the local refractive index
change of the medium surrounding the Ag NPs, deriv-
ing from the volume phase transition of the gel shell.17
The nonradiative energy loss paths, which are highly
dependent on the nature of the environment around
the metal particles,50 possibly provide a second scenario
for the fluorescence change. As the glucose concentra-
tion increases, the polymer chains tend to expand.
However, the Ag core NPs offer the restoring force to
hinder the network expansion, introducing an elastic
tension in the bond at the polymer-Ag interface that
would induce strain at the relaxed Ag NP surface,51 cre-
ating interfacial states that quench the PL. The cova-
lent bonds formed between the boronic acid and cis-
diols are reversible.20 As glucose is removed from the
bathing medium by dialysis against very frequently
changed water, the dissociation equilibrium shifts back
from boronate ester to boronic acid, leading to a recov-
ery of the fluorescence (9396% and 99% of the origi-
nal basal values for the hybrid nanogels containing and
without DMAEA, respectively) upon the removal of glu-
cose even after five cycles, thus providing a highly re-
producible signal (Figure 4D), which is crucial for quan-
titative applications. This high reproducibility reflects
the appropriate but not too great enhancement effect
of DMAEA on the binding affinity of PBA to glucose.
Since the changes in the optical properties of the Ag
core NPs are caused by the glucose-induced volume
phase transitions of the gel shell, the kinetics of the
fluorescent response will depend on how quickly the
nanogel shrinks or swells in response to a change in glu-
cose concentration. It has been determined that the
rate of the stimuli-induced volume phase transition of
a hydrogel particle of 200350 nm diameter is on the
order of 100 ns.52,53 We expect that the kinetics of the
glucose-induced fluorescent response of our sub-200
nm hybrid nanogels should be on the hundreds nano-
second scale or even faster. One possible application of
this optical feature is to noninvasively sense and im-
age the glucose level within living systems.
Glucose sensors should be free from significant in-
terferences from the nonglucose constituents of blood.
The concentration of pyruvate, galactose, and fructose
in blood is 0.1 mM,54,55 thus it is unlikely that these
compounds will interfere significantly with the glucose
reading. However, the L-lactate concentration in a rest-
ing healthy adult is approximately 0.360.75
mM,21,22,54,55 which could potentially be a significant in-
terferent. In our design, the DMAEA group can stabilize
the boronate anion which makes the attack of the bo-
ronic group by lactate unfavorable although the slightly
positively charged DMAEA moiety will experience
charge attraction on encountering lactate. As a result
of the competitive effects on DMAEA, a decrease of
24% in glucose-induced PL quenching was observed
in the presence of 0.8 mM L-lactate, corresponding to a
24% lower apparent concentration of glucose. On
the contrary, the 0.8 mM lactate caused the non-
DMAEA modified AVD-4 to indicate a 7% higher ap-
parent glucose concentration due to its competitive
binding with the PBA. Clearly, the signaling ability of
the DMAEA-containing hybrid nanogels provides excel-
lent sensitivity and selectivity to glucose over lactate.
The influence of metal ions on the glucose detection
ability of the hybrid nanogels was also examined. The
relative error of glucose concentration reading
(0.420.0 mM) in the presence of 1.0 mM common
metal ions found in biological systems, such as K
(0.08%), Ca2 (0.23%), Na (0.05%), Mg2
(0.21%), Al3 (0.34%), Zn2 (0.23%), Fe3
(0.52%), and Cu2 (0.85%), is generally within the
range of 1% after taking account of the experimen-
tal errors. The slight interference from metal ions is pos-
sibly associated with the coordination between the
metal ions and the boronic acid groups, or simply the
enhancement of ionic strength. Both effects would
weaken the Donnan potential.
Having demonstrated the signaling ability of the hy-
brid nanogels, we further applied them to the storage
and delivery of insulin. The porous network structure of
the gel shell is particularly well suited to trap insulin, re-
sulting in a high drug loading capacity. The yields of
FITC-insulin loaded into the hybrid nanogels were de-
termined to be 38.3, 35.7, and 33.1 wt % (expressed as
the mass of loaded drug per unit weight of dried hybrid
nanogels) for AVD-1, AVD-2, and AVD-3, respectively.
Considering the approximate concentrations of the
Figure 5. Releasing profiles of FITC-insulin from AVD-1 (A), AVD-2 (B), and AVD-3 (C), in the presence of 20 (9), 10 (), 5
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hybrid nanogel dispersions, these insulin loading capa-
bilities are equivalent to 418.2, 404.3, and 428.4 IU/L, re-
spectively. It should be noted that the hybrid nanogels
can be concentrated and adjusted to an appropriate
concentration to cover an even higher dose. Figure
5AC shows the in vitro insulin releasing profiles from
the hybrid nanogels measured by the dialysis method
for 46 h in pH  7.4 PBS at 37 °C. A blank release experi-
ment of free FITC-insulin (5800 Da) solution with an
equivalent amount of drug to that trapped in AVD-1
was also performed, showing that the dialysis mem-
brane (cutoff 1200014000 Da) played a negligible role
in the release kinetics. The much slower insulin release
from the hybrid nanogels compared to the free drug so-
lution indicates a sustained release process. The re-
lease can be further regulated by varying the glucose
concentration in the releasing medium, demonstrating
that the insulin could be released in a repeated on/off
manner with fluctuating glucose level. At higher glu-
cose levels (10 mM in diabetic patients), the DMAEA-
containing hybrid nanogels can deliver a high amount
of drug (5691%, depending on the glucose concen-
trations and nanogel types), standing in vivid contrast
with the low release efficiency of AVD-4 under the same
conditions (Supporting Information, Figure S5). The
time scales for insulin delivery are compatible with the
patient’s needs, since the DMAEA-containing hybrid
nanogels could deliver insulin in less than 30 min, and
the sustained release over 2 days may also meet the
basal needs. Although the current results are obtained
from in vitro studies, their characteristics for self-
regulated insulin delivery could be extremely impor-
tant in the treatment of diseases.
For future biological applications, the hybrid nano-
gels should be non- or low-cytotoxic. Assuming a re-
quired delivery of 1 mg/day ( 24 IU/day), the thera-
peutic amount of our hybrid nanogels need only be
1.54.0 mg after taking account of the release amount.
A typical adult has a blood volume of between 4.7 and
5 L, with females generally having a smaller blood vol-
ume than males.54,55 That is, the concentration of the
hybrid nanogels could be less than 4 	g/mL used in the
bloodstream. As shown in Figure 6, the hybrid nano-
gels were non- or low-cytotoxic to Cos7 cells after incu-
bation for 24 h at concentrations of up to 7.5 	g/mL.
Considering the possibility of degradation of the poly-
mer gel during the long circulation, the potential cyto-
toxicity of free Ag NPs was also addressed. Once again,
the free Ag NPs exhibit low cytotoxicity at all the stud-
ied concentrations.
CONCLUSIONS
We have designed an advanced glucose-sensitive
platform with high sensitivity and selectivity at physi-
ological pH and temperature on the basis of
inorganicorganic coreshell structured hybrid nano-
gels. The beauty of this class of smart hybrid nanogels,
which differentiates it from other examples of glucose
sensors and nanoparticle-based insulin delivery sys-
tems, is the integration of glucose detection and self-
regulated insulin delivery into a single nano-object. The
chemical reagents and the developed hybrid nanogels
are nontoxic to cells. The fluorescent functionality may
allow noninvasive tracking of the distribution of the in-
sulin carriers within the body. The multifunctional hy-
brid nanogels should promise a new efficient modality
for single measurement of glucose concentrations, as
well as for in vivo animal models and future clinical tri-
als in diabetes management. We anticipate that the ap-
proach presented here may serve as a good starting
point for the fabrication of multifunctional nanomateri-
als with a huge potential in biomedicine-related areas.
METHODS
Chemicals. All chemicals were purchased from Aldrich.
2-(Dimethylamino)ethyl acrylate (DMAEA) was purified with neu-
tral Al2O3. The lyophilized fluorescein isothiocyanate-labeled in-
sulin (FITC-insulin) from bovine pancreas (5800 Da), sodium
L-lactate, silver nitrate (AgNO3), sodium citrate (Na3C6H5O7 · H2O),
sodium borohydrate (NaBH4), 4-vinylphenylboronic acid (VPBA),
N,N=-methylenebisacrylamide (MBAAm), 2,2=-azobis(2-
methylpropionamidine) dihydrochloride (AAPH), and sodium
dodecyl sulfate (SDS) were used as received without further pu-
rification. The water used in all experiments was of Millipore
Milli-Q grade.
Synthesis of Ag NPs. Citrate-stabilized Ag NPs were first pre-
pared by dropwise addition of fresh NaBH4 solution (10.6 mM,
2.5 mL) to an aqueous solution of AgNO3 (0.1 mM, 200 mL) in
the presence of sodium citrate (0.1 mM) under vigorous stirring.
The resultant solution was stirred for 1 h and aged for 7 days at
ambient conditions before use. The long aging time is necessary
for completely degrading the reducing agent of NaBH4. SDS-
stabilized Ag NPs were obtained by adding 0.053 g SDS into 100
mL of aqueous solution of citrate-stabilized Ag NPs in a 250 mL
round-bottom flask equipped with a stirrer, a N2 gas inlet, and a
condenser, and then aging the mixture for 10 h.
Synthesis of Ag@p(VPBADMAEA) Hybrid Nanogels. In a 250 mL
round-bottom flask equipped with a stirrer, a N2 gas inlet, and a
condenser, 100 mL of as-prepared aqueous solution of SDS-
stabilized Ag NPs was heated to 30 °C, followed by the addition
of VPBA (0.970 g), DMAEA, and MBAAm (0.007 g) under stirring.
Figure 6. In vitro cytotoxicity of the hybrid nanogels and Ag
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After 30 min, the temperature was raised to 70 °C and polymeri-
zation was initiated by adding 1 mL of 0.105 M AAPH. The polym-
erization reaction was allowed to proceed for 5 h. The solution
was centrifuged twice at 6000 rpm (30 min, Thermo Electron Co.
SORVALL RC-6 PLUS superspeed centrifuge) with the superna-
tant discarded and the precipitate redispersed in 200 mL deion-
ized water. The resultant hybrid nanogels were further purified
by 3 days of dialysis (Spectra/Por molecularporous membrane
tubing, cutoff 1200014000 Da MWCO, the same as below)
against very frequently changed water at room temperature
(22 °C). The resultant hybrid nanogels made with the feeding
of DMAEA  0.20, 0.10, 0.05, and 0 mL are coded as AVD-1,
AVD-2, AVD-3, and AVD-4, respectively.
Insulin Loading and Release. FITC-insulin was loaded to the hy-
brid nanogels by the complexation method. A stock solution of
FITC-insulin (1 mg/mL) was prepared in 0.005 M phosphate
buffer solution (PBS) of pH  7.38, and stored in the refrigera-
tor (4 °C). The pH value of the hybrid nanogel (5 mL) was ad-
justed to 9.0 by using dilute NaOH solution. This dispersion was
stirred in an ice water bath for 30 min; 1 mL of FITC-insulin solu-
tion was then added dropwise to the vial. The immediate cloud-
ing revealed the hydrogen bonding complexation of the OH
groups in the insulin molecules with the boronic acid groups in
the hybrid nanogels. After stirring overnight, the suspension was
centrifuged at 6000 rpm for 30 min at 22 °C. To remove free
drug, the precipitate was redispersed in 5 mL of PBS of pH 
7.38 and further purified by repeated centrifugation and wash-
ing. Finally, the precipitate was redispersed in 1 mL of PBS of pH
 7.38. All the upper clear solutions were collected, and the con-
centration of free drug was determined by fluorescence spec-
trometry at 518 nm upon excitation at 492 nm. The amount of
loaded FITC-insulin in hybrid nanogels was calculated from the
decrease in drug concentration. The loading content is ex-
pressed as the mass of loaded drug per unit weight of dried hy-
brid nanogels.
The in vitro release test of FITC-insulin from the hybrid nano-
gels was evaluated by the dialysis method. A dialysis bag filled
with 1 mL of purified insulin-loaded hybrid nanogel dispersion
was immersed in 50 mL of 0.005 M buffer solutions of pH  7.38
at various glucose concentrations. The released FITC-insulin out-
side of the dialysis bag was sampled at defined time intervals
and assayed by fluorescence spectrometry at 518 nm upon exci-
tation at 492 nm. Cumulative release is expressed as the total
percentage of drug released through the dialysis membrane
over time. The release experiments were also performed to show
the evolution of the release kinetics in response to glucose con-
centration changes.
In Vitro Cytotoxicity. Cos 7 cells were plated in DMEM (Invitro-
gen, Carlsbad, CA) with 10% FCS at 10000 cells per well in two
96-well plates and allowed to grow overnight at 37 °C in 5% CO2
incubator. The following day, the media were aspirated from
the wells and the cells were treated with various concentrations
of nanoparticles suspended in growing media, using three wells
per concentration. The first plate was assayed 2 h after nanopar-
ticle addition and the second one was assayed after 24 h. The
percentage of DMEM and FCS was kept constant in each well.
To estimate the amount of cell death, the wells were washed
twice with phosphate-buffered saline, followed by the addition
of 120 	L of 16.7% CellTiter 96 Aqueous One Solution (Promega,
Madison, WI) in cell culture media in each well and further incu-
bation at 37 °C in 5% CO2. After 3.5 h, three portions of the solu-
tion obtained from each well were transferred to three respec-
tive wells of a 96-well plate. Absorbance was measured at 490
nm using a plate reader. Percentage of live cells was calculated
relative to wells in same media conditions as the experimental
wells but without any nanoparticles.
Characterization. The UVvis absorption spectra were ob-
tained on a Thermo Electron Co. Helios 
 UVvis spectrometer.
The PL spectra of the hybrid nanogel dispersions at various glu-
cose concentrations were obtained on a JOBIN YVON Co.
FluoroMax-3 spectrofluorometer equipped with a Hamamatsu
R928P photomultiplier tube and a calibrated photodiode for ex-
citation reference correction from 200 to 980 nm, with an inte-
gration time of 1 s. To confirm all emissions, the PL spectra were
also recorded on a VARIAN CARY Eclipse fluorescence spectro-
photometer equipped with R928 photomultiplier tubes and self-
optimized light filters. The pH values were measured on a MET-
TLER TOLEDO SevenEasy pH meter. The transmission electron
microscopy (TEM) images were taken on a FEI TECNAI transmis-
sion electron microscope at an accelerating voltage of 120 kV.
Approximately 10 	L of the diluted hybrid nanogel dispersion
was air-dried on a carbon-coated copper grid for the TEM meas-
urements. The hydrodynamic radius (Rh) was determined on a
standard laser light scattering spectrometer (BI-200SM)
equipped with a BI-9000 AT digital time correlator and a HeNe
laser (35 mW, 633 nm) as the light source. All hybrid nanogel dis-
persions were passed through Millipore Millex-HV filters with a
pore size of 0.80 	m to remove dust before the DLS
measurements.
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